title: Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats.
abstract: Coffee, a rich source of natural products, including caffeine, chlorogenic acid, and diterpenoid alcohols, has been part of the human diet since the 15th century. In this study, we characterized the effects of Colombian coffee extract (CE), which contains high concentrations of caffeine and diterpenoids, on a rat model of human metabolic syndrome. The 8-9 wk old male Wistar rats were divided into four groups. Two groups of rats were fed a corn starch-rich diet whereas the other two groups were given a high-carbohydrate, high-fat diet with 25% fructose in drinking water for 16 wk. One group fed each diet was supplemented with 5% aqueous CE for the final 8 wk of this protocol. The corn starch diet contained ~68% carbohydrates mainly as polysaccharides, whereas the high-carbohydrate, high-fat diet contained ~68% carbohydrates mainly as fructose and sucrose together with 24% fat, mainly as saturated and monounsaturated fat from beef tallow. The high-carbohydrate, high-fat diet-fed rats showed the symptoms of metabolic syndrome leading to cardiovascular remodeling and nonalcoholic fatty liver disease. CE supplementation attenuated impairment in glucose tolerance, hypertension, cardiovascular remodeling, and nonalcoholic fatty liver disease without changing abdominal obesity and dyslipidemia. This study suggests that CE can attenuate diet-induced changes in the structure and function of the heart and the liver without changing the abdominal fat deposition.
authors.affiliation: Department of Biological and Physical Sciences, University of Southern Queensland, Toowoomba, Queensland, Australia.
authors.forename: Sunil K
authors.initials: SK
authors.lastname: Panchal
authors.forename: Hemant
authors.initials: H
authors.lastname: Poudyal
authors.forename: Jennifer
authors.initials: J
authors.lastname: Waanders
authors.forename: Lindsay
authors.initials: L
authors.lastname: Brown
mesh_terms: D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D002110:Caffeine / Q000032:analysis / Q000627:therapeutic use; D003069:Coffee / Q000737:chemistry; D059305:Diet, High-Fat / Q000009:adverse effects; D019422:Dietary Sucrose / Q000009:adverse effects; D004224:Diterpenes / Q000032:analysis / Q000627:therapeutic use; D005234:Fatty Liver / Q000209:etiology / Q000517:prevention & control*; D005632:Fructose / Q000009:adverse effects; D018149:Glucose Intolerance / Q000209:etiology / Q000517:prevention & control*; D006331:Heart Diseases / Q000209:etiology / Q000517:prevention & control*; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control*; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008297:Male; D024821:Metabolic Syndrome / Q000178:diet therapy* / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D065626:Non-alcoholic Fatty Liver Disease; D056128:Obesity, Abdominal / Q000178:diet therapy / Q000209:etiology / Q000473:pathology; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D020257:Ventricular Remodeling
chemical_list: D019440:Anti-Obesity Agents; D003069:Coffee; D019422:Dietary Sucrose; D004224:Diterpenes; D005632:Fructose; D002110:Caffeine